NEW YORK, April 10, 2017 /PRNewswire/ -- The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market. On the other hand, accuracy and standardization concerns in diagnostic testing and the lack of skilled technical personnel are some of the key factors limiting the growth of the market. Read the full report: http://www.reportlinker.com/p04819004/Next-Generation-Sequencing-NGS-Market-by-Product-Hiseq-Miseq-Hiseq-X-Ten-X-Five-NextSeq500-Ion-Proton-PGM-Ions5-PacBio-RSII-Services-Targeted-RNA-Exome-De-Novo-Application-Diagnostics-Biomarker-Agriculture-Global-Forecasts-to-202.htmlOn the basis of product and service, the NGS market is categorized into pre-sequencing products and services, NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics. In 2017, the consumables segment is expected to account for the largest share of the market. On the basis of technology, the global NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing. In 2017, the SBS technology is expected to account for the largest share of the market, majorly due to the development of new and advanced NGS platforms, the increasing demand for Illumina's systems (including the HiSeq series and MiSeq), and the growing demand for NextSeq and HiSeq X Ten. Based on applications, the market is categorized into six segments, namely, diagnostics, drug discovery, biomarker discovery, precision medicine, agriculture & animal research, and other application. The diagnostics application segment is expected to account for the major share of the global NGS market owing to the increasing focus of key market players on providing & developing NGS-based diagnostic tests and the growing adoption of NGS-based diagnostic tests related to oncology and infectious diseases. On the basis of end user, the market is segmented into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these end users, the hospitals and clinics segment is expected to register the highest CAGR due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics. For instance, in November 2016, Illumina, Inc. entered into an agreement with Mayo Clinic (U.S.) to install its BaseSpace Clarity LIMS in Mayo's specific laboratories. Geographically, the NGS market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the market in 2017, followed by Europe. The market in North America is primarily driven by the technological advancements, availability of commercial solutions for NGS data analysis, and the strong presence of key players in this region. However, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022, due to the improving healthcare infrastructure and favorable government initiatives in this region. The global NGS market is highly competitive, with a large number of global and local players. In 2016, the global NGS market was dominated by Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Pacific Biosciences of California, Inc. (U.S.), and together held the majority share of the NGS platforms market. New product launches, product enhancements, agreements, and partnerships were the major strategies adopted by market players to achieve growth in the market. Research Coverage
This report studies the next-generation sequencing (NGS) market based on product & service, application, technology, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions. Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the next-generation sequencing market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares. The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios and services offered by the major players in the next-generation sequencing market. The report analyzes the next generation sequencing market based on product & service, application, technology, end user, and region - Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the next-generation sequencing market - Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various next-generation sequencing products and services across geographies - Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the next-generation sequencing market - Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the next-generation sequencing market Read the full report: http://www.reportlinker.com/p04819004/Next-Generation-Sequencing-NGS-Market-by-Product-Hiseq-Miseq-Hiseq-X-Ten-X-Five-NextSeq500-Ion-Proton-PGM-Ions5-PacBio-RSII-Services-Targeted-RNA-Exome-De-Novo-Application-Diagnostics-Biomarker-Agriculture-Global-Forecasts-to-202.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com__________________________Contact Clare: [email protected]US: (339)-368-6001Intl: +1 339-368-6001
Advertisement
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/next-generation-sequencing-ngs-market-by-product-hiseq-miseq-hiseq-x-tenx-five-nextseq500-ion-proton-pgm-ions5-pacbio-rsii-services-targeted-rna-exome-de-novo--application-diagnostics-biomarker-agriculture--300437529.html
SOURCE Reportlinker
